Brief: Nabriva Announces Availability Of Xenleta In A 10-Count Oral Pack
11/11/2021 12:11
Nov 11 (Reuters) - Nabriva Therapeutics PLC NBRV.O :
* NABRIVA ANNOUNCES AVAILABILITY OF XENLETA® (LEFAMULIN) IN
A
10-COUNT ORAL PACK
* NABRIVA THERAPEUTICS PLC - ORAL FORMULATION OF XENLETA NOW
AVAILABLE IN A 10-COUNT ORAL PACK IN U.S. THROUGH MAJOR
SPECIALTY DISTRIBUTORS
Source text for Eikon: ID:nGNX4H1YT0
Further company coverage: NBRV.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Nabriva Therapeutics
See all newsBrief: Nabriva Therapeutics And Units Enter Asset Purchase Agreement With Sumitomo Pharma
Brief: Nabriva Therapeutics Says Received Delisting Determination Letter From Nasdaq
Brief: Nabriva Therapeutics Receives Notice Of Delisting Or Failure To Satisfy Continued Listing Rule From Nasdaq
Brief: Nabriva Therapeutics - On Jan 31, Co's Unit Entered Into Letter Agreement With 2 Units Of Merck & Co, About Distribution Agreement, Dated July 15, 2020
Brief: Nabriva Therapeutics Provides Corporate Update